| Name | Title | Contact Details |
|---|
Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Connecticut Hospital Association is a Wallingford, CT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
FocusOne is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AdvanSource Biomaterials Corporation is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.